Register

scientific Sessions

  • Home
  • Scientific Sessions

Tumour Suppressor Molecules in Cancer Therapy

Tumour suppressor molecules are critical in regulating cell growth and preventing malignancies. In cancer therapy, strategies aim to restore or mimic the function of these molecules, such as p53 and RB, which are often inactivated in tumors. At the Cancer Research and Development Conference 2025, experts will present advances in gene therapy, small molecules, and targeted delivery systems that enable tumour suppressors' reactivation. These promising avenues aim to inhibit cancer progression and improve therapeutic outcomes, offering a novel approach to cancer treatment.

Related Sessions

Advances in Nanotechnology for Cancer Treatment
Cellular Therapies Beyond CAR-T
The Role of Epigenetics in Cancer Diagnosis
Cancer Genomics and Epigenomics
Liquid Biopsy Innovations
Immunomodulatory Molecules in Cancer Therapy
Pediatric Oncology
Advances in Cancer Genetics and Genomics
Novel Cancer Vaccines
Systems Biology in Cancer Research
Cutting-Edge Therapies in Cancer Treatment
Tumour Suppressor Molecules in Cancer Therapy
Molecular Imaging Agents for Cancer
Organoids and 3D Bioprinting in Cancer R&D
Don't miss our future updates!

Get in Touch